ANPC.Y Stock Overview
ANGLE plc, a medical diagnostic company, engages in developing cancer diagnostics products.
Snowflake Score | |
---|---|
Valuation | 2/6 |
Future Growth | 2/6 |
Past Performance | 0/6 |
Financial Health | 6/6 |
Dividends | 0/6 |
My Notes
NewNotes are coming soon
ANGLE plc Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | UK£3.55 |
52 Week High | UK£21.00 |
52 Week Low | UK£3.55 |
Beta | 0.68 |
1 Month Change | -43.46% |
3 Month Change | -43.46% |
1 Year Change | -76.01% |
3 Year Change | -60.52% |
5 Year Change | n/a |
Change since IPO | -73.51% |
Recent News & Updates
Recent updates
Shareholder Returns
ANPC.Y | US Medical Equipment | US Market | |
---|---|---|---|
7D | -11.2% | 4.7% | 2.9% |
1Y | -76.0% | -8.4% | -8.5% |
Return vs Industry: ANPC.Y underperformed the US Medical Equipment industry which returned -8.4% over the past year.
Return vs Market: ANPC.Y underperformed the US Market which returned -8.5% over the past year.
Price Volatility
ANPC.Y volatility | |
---|---|
ANPC.Y Average Weekly Movement | n/a |
Medical Equipment Industry Average Movement | 8.6% |
Market Average Movement | 6.8% |
10% most volatile stocks in US Market | 17.6% |
10% least volatile stocks in US Market | 2.8% |
Stable Share Price: Insufficient data to determine ANPC.Y's volatility over the past 3 months.
Volatility Over Time: Insufficient data to determine ANPC.Y's volatility change over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
1994 | 128 | Andrew David Newland | https://angleplc.com |
ANGLE plc, a medical diagnostic company, engages in developing cancer diagnostics products. The company develops and commercializes Parsortix cell separation system, which captures and harvests circulating tumor cells in metastatic breast cancer patient blood; and HyCEAD multiplex analysis system for routine and focused multiplex analysis of DNA, RNA or protein biomarkers. The company was founded in 1994 and is based in Guildford, the United Kingdom.
ANGLE plc Fundamentals Summary
ANPC.Y fundamental statistics | |
---|---|
Market Cap | US$90.85m |
Earnings (TTM) | -US$20.25m |
Revenue (TTM) | US$1.39m |
65.3x
P/S Ratio-4.5x
P/E RatioIs ANPC.Y overvalued?
See Fair Value and valuation analysisEarnings & Revenue
ANPC.Y income statement (TTM) | |
---|---|
Revenue | UK£1.14m |
Cost of Revenue | UK£1.04m |
Gross Profit | UK£94.00k |
Other Expenses | UK£16.64m |
Earnings | -UK£16.55m |
Last Reported Earnings
Jun 30, 2022
Next Earnings Date
Jun 02, 2023
Earnings per share (EPS) | -0.064 |
Gross Margin | 8.27% |
Net Profit Margin | -1,456.87% |
Debt/Equity Ratio | 0% |
How did ANPC.Y perform over the long term?
See historical performance and comparison